| Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
|---|
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | US20080081915 Process For Producing Epoxytriazole Derivative |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/02/2008 | EP1482904B1 Uv absorber compositions comprising a hydroxyphenyltriazine compound |
| 04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101153028A Compounds with antimicrobial antiviral activity |
| 04/01/2008 | US7351731 Low toxicity; antifungal agents effective against life-threatening systemic mycoses caused by C. neoformans, Aspergillus species, Candida species; prevent the synthesis of ergosterol by inhibiting the enzyme lanosterol demethylase; N-myristoyl transferase inhibition; increased lipophilicity |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 03/27/2008 | WO2008034644A2 Process for making anastrozole |
| 03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
| 03/27/2008 | WO2008004088A3 Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding |
| 03/27/2008 | WO2007132354A3 Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
| 03/27/2008 | US20080076933 Process for making anastrozole |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348437 Compound with a hydroxamate and a benzophenone group, and a functional group of rhodamine, oligonucleotides, azides, alkynes, biotin, or p-nitrophenyl; binding the active compound to the active site, forming an active compound-metalloprotease adduct; determining the potency of the inhibitor |
| 03/25/2008 | US7348345 Nonnucleoside reverse transcriptase inhibitors |
| 03/20/2008 | WO2007140174A3 Compounds and methods for modulating fxr |
| 03/20/2008 | WO2007139960A3 Compounds that modulate hsp90 activity and methods for identifying same |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | US20080070965 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | EP1898903A2 Inhibitors of akt activity |
| 03/19/2008 | CN101146872A Chromophore coated metal oxide particles |
| 03/19/2008 | CN101146777A Carboxanilides as microbiocides |
| 03/19/2008 | CN101143864A Novel triazolo pyrimidine compounds |
| 03/18/2008 | US7344706 UV absorber compositions comprising a hydroxyphenyltriazine compound |
| 03/18/2008 | CA2429378C Improved process for water soluble azole compounds |
| 03/18/2008 | CA2337280C A process for preparing substituted benzoyl cyanide amidinohydrazones |
| 03/18/2008 | CA2327784C Triazolones with a neuroprotective action |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2007139952A3 Method for the preparation of triazole compounds with hsp90 modulating activity |
| 03/13/2008 | US20080064748 Substituted enaminones, their derivatives and uses thereof |
| 03/12/2008 | EP1896491A2 Monoazole ligand platinum analogs |
| 03/12/2008 | EP1896429A2 A purification process for anastrozole intermediate |
| 03/12/2008 | EP1896398A2 An impurity of anastrozole intermediate, and uses thereof |
| 03/12/2008 | CN101139324A Amido protecting agent and preparation method thereof |
| 03/12/2008 | CN100374516C Printing process using specified azo compounds |
| 03/12/2008 | CN100374426C Method for preparing benzotriazole compound |
| 03/11/2008 | US7342037 Anti-inflammatory medicaments |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2007134846A3 Process for purification of anastrozole |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/05/2008 | EP1893718A2 Electroluminescent metal complexes with triazoles and benotriazoles |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
| 03/05/2008 | EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1893020A1 Derivatives of a 1-phenyltriazole as antiparasitic agents |
| 02/28/2008 | WO2008024784A1 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/27/2008 | EP1891002A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 02/27/2008 | EP1890694A1 Phenylalkyl substituted heteroaryl devivatives |
| 02/27/2008 | CN101133030A Menthane carboxamide derivatives having cooling properties |
| 02/27/2008 | CN101130522A Novel method for synthesizing fungicide tebuconazole |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/21/2008 | WO2008021871A2 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2007149448A3 Pyrazinones as cellular proliferation inhibitors |
| 02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
| 02/21/2008 | US20080045533 Novel cyclohexyl sulphones |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | CA2211868C Methods of inhibiting corrosion using n-halo-azoles |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080038225 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | EP1299390B1 Pyrimidine compounds and their use in the preparation of a triazolo -pyrimidine carba nucleoside |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/07/2008 | WO2008014811A1 PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES |
| 02/07/2008 | US20080033178 Ionic Liquids |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/06/2008 | EP1135239B1 Wood preservative formulations |
| 02/06/2008 | CN101119978A HSP90-inhibiting triazole derivatives |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326790 Diphenylisoxazole compounds and hydro isomers thereof |
| 02/05/2008 | US7326744 Low dusting crystal transformations of 2,2′-methylenebis[4-(1,1,3,3-tetramethylbutyl)-6-benzotriazolylphenol] and mixture thereof, method for preparing them, and ultraviolet light absorber using them |
| 02/05/2008 | US7326726 Biaryl substituted triazoles as sodium channel blockers |
| 02/05/2008 | CA2295892C Process for the preparation of acylated cyclic 1,3-dicarbonyl compounds |